It's not as if a new molecule has to be put through it's paces in the final wash up of getting our opioids approved by the FDA - the molecule has already been approved.
We are merely looking at a different delivery system. Yes we have to go back to phase I / II - but the FDA may well be attracted to the proposition of minimal side effects (side effects being their greatest dislike of these substances).
Some products with perceived greater merit have been fast tracked such as clot-busting molecules for stroke (previously approved for heart attack).
In saying this POH does have to land a deal - but if they do it with a reputable company, then there is far greater muscle for negotiating with such as the FDA.
- Forums
- ASX - By Stock
- AVE
- New Investor Fact Sheet
New Investor Fact Sheet, page-22
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $408 | 154.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
61 | 90794613 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 54998583 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 90194613 | 0.002 |
22 | 76000009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 54997247 | 12 |
0.004 | 19981337 | 16 |
0.005 | 19749333 | 10 |
0.006 | 20865067 | 11 |
0.007 | 10865221 | 9 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |